Table 3. Regression analyses of development of CIN during a 100-month follow-up period by demographic characteristics, clinical properties, and laboratory parameters.
| Parameters | Univariable analysis | Multivariable analysis | ||
|---|---|---|---|---|
| OR (95%CI) | p-value | OR (95%CI) | p-value | |
| Age | 1.03 (1.00–1.06) | 0.029 | 1.04 (1.0–1.08) | 0.048 |
| Gender | 0.81 (0.37–1.77) | 0.598 | – | |
| Hypertension | 0.61 (0.30–1.20) | 0.157 | – | |
| Diabetes mellitus | 0.61 (0.30–1.23) | 0,173 | – | |
| Chronic kidney disease | 0.33 (0.09–1.24) | 0.103 | 0.37 (0.06–2.15) | 0.274 |
| Smoking | 0.58 (0.28–1.19) | 0.140 | – | |
| Peripheral arterial disease | 4.72 (1.44–15.48) | 0.010 | 0.13 (0.02–0.75) | 0.023 |
| Left ventricle ejection fraction | 0.95 (0.92–0.98) | 0.004 | 0.96 (0.92–1.0) | 0.054 |
| Hemoglobin, gr/dL | 0.93 (0.77–1.12) | 0.461 | – | |
| Platelet, 103/μL | 1.30 (0.09–17.3) | 0.839 | – | |
| Glucose, mg/dL | 3.65 (0.74–17.8) | 0.109 | 1.64 (0.21–12.4) | 0.629 |
| C-reactive protein | 1.13 (1.03–1.25) | 0.007 | 1.10 (1.0–1.22) | 0.048 |
| Total cholesterol | 1.0 (0.99–1.01) | 0.281 | – | |
| Number of sick vessels (multiple total vessels are present/not present) | 0.49 (0.21–1.12) | 0.094 | 0.53 (0.18–1.52) | 0.240 |
| Rentrop (good/poor) | 1.31 (0.66–2.60) | 0.436 | – | |
Bold indicates significant value.